Ohine
liked
$DBS (D05.SG)$
DBS is one of the best stock in Singapore with strong dividend and fundamental business. Recently, the stock price has completed a 200% Fib move from the last major bottom to the recent top, a 17 to 17 sgd move. At this point, this stock is not a buy anymore depite being cheaper evaluation than when it break out (lower P/E). I will be waiting for a retracement, potentially by end of Oct this year to buy back at break out levels.
DBS is one of the best stock in Singapore with strong dividend and fundamental business. Recently, the stock price has completed a 200% Fib move from the last major bottom to the recent top, a 17 to 17 sgd move. At this point, this stock is not a buy anymore depite being cheaper evaluation than when it break out (lower P/E). I will be waiting for a retracement, potentially by end of Oct this year to buy back at break out levels.

25
7
Ohine
liked
Ohine
liked
• US markets: Stocks rise for 2nd day & are out of correction. Volatility ahead with April 2 tariff deadline. Healthcare, Energy & Utilities lead market overnight.
• Aussie markets: Out of correction. Gold, and Industrials stocks are shining this year and that will probably continue.
• Stocks to watch: Amazon, Google back into bear markets. Meta, Apple, Microsoft snap out of bear markets. Eyes on Tesla down 51...
• Aussie markets: Out of correction. Gold, and Industrials stocks are shining this year and that will probably continue.
• Stocks to watch: Amazon, Google back into bear markets. Meta, Apple, Microsoft snap out of bear markets. Eyes on Tesla down 51...
From YouTube
47
1
Ohine
liked
$Esperion Therapeutics (ESPR.US)$ FY2025 EPS Estimates for ESPR Lifted by Cantor Fitzgerald
Written by MarketBeat
March 15, 2025 Cantor Fitzgerald Brokers Raise Earnings Estimates for ESPR
Cantor Fitzgerald raised their FY2025 earnings per share estimates for Esperion Therapeutics in a report released on Wednesday, March 12th. Cantor Fitzgerald analyst K. Kluska now forecasts tha...
Written by MarketBeat
March 15, 2025 Cantor Fitzgerald Brokers Raise Earnings Estimates for ESPR
Cantor Fitzgerald raised their FY2025 earnings per share estimates for Esperion Therapeutics in a report released on Wednesday, March 12th. Cantor Fitzgerald analyst K. Kluska now forecasts tha...



+1
16
1
Ohine
liked
13
5
Ohine
liked